Regents Of The University Of California Revolution Medicines, Inc. Transaction History
Regents Of The University Of California
- $179 Million
- Q2 2024
Shares
2 transactions
Others Institutions Holding RVMD
# of Institutions
242Shares Held
161MCall Options Held
251KPut Options Held
133K-
Vanguard Group Inc Valley Forge, PA14.4MShares$803 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA13.7MShares$763 Million0.1% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$749 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA9.76MShares$545 Million1.83% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$423 Million3.9% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $4.9B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...